J-Pharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 18

Employees

  • Stock Symbol
  • 520A

Stock Symbol

  • Share Price
  • $1.98
  • (As of Friday Closing)

J-Pharma General Information

Description

J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • VORT Hamamatsucho II, 8th Floor
  • 1-10-11 Hamamatsucho, Minato-ku
  • Tokyo, Minato-ku 105-0013
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
TKS
Corporate Office
  • VORT Hamamatsucho II, 8th Floor
  • 1-10-11 Hamamatsucho, Minato-ku
  • Tokyo, Minato-ku 105-0013
  • Japan
+81

J-Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

J-Pharma Stock Performance

As of 20-Nov-2026, J-Pharma’s stock price is $1.98. Its current market cap is $35.9M with 18.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.98 $2.04 $1.60 - $5.10 $35.9M 18.1M 393K

J-Pharma Financials Summary

As of 31-Mar-2026, J-Pharma has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Mar-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 66,453 66,453
Revenue 0 0
EBITDA (9,822) (11,413)
Net Income (9,830) (11,436)
Total Assets 29,785 29,785 19,090 7,977
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

J-Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore J-Pharma‘s full profile, request access.

Request a free trial

J-Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore J-Pharma‘s full profile, request access.

Request a free trial

J-Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single s
Drug Discovery
Tokyo, Japan
18 As of 2026

San Diego, CA
 

Illkirch-Graffenstaden, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

J-Pharma Competitors (75)

One of J-Pharma’s 75 competitors is Arcturus Therapeutics Holdings, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arcturus Therapeutics Holdings Formerly VC-backed San Diego, CA
Transgene Corporation Illkirch-Graffenstaden, France
Alaunos Therapeutics Formerly VC-backed Fort Lauderdale, FL
TME Pharma Formerly VC-backed Berlin, Germany
iBio Corporation San Diego, CA
You’re viewing 5 of 75 competitors. Get the full list »

J-Pharma Patents

J-Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026132464-A Cholangitis treatment Pending 05-Feb-2025
EP-4653014-A1 Biliary tract cancer treatment agent Pending 16-Jan-2023
WO-2024154717-A1 Biliary tract cancer treatment agent Inactive 16-Jan-2023
US-20250041281-A1 Method of treating biliary tract cancer Pending 16-Jan-2023
WO-2022102687-A1 Therapeutic agent for cancer Inactive 11-Nov-2020
To view J-Pharma’s complete patent history, request access »

J-Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

J-Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view J-Pharma’s complete esg history, request access »

J-Pharma FAQs

  • When was J-Pharma founded?

    J-Pharma was founded in 2005.

  • Where is J-Pharma headquartered?

    J-Pharma is headquartered in Tokyo, Japan.

  • What is the size of J-Pharma?

    J-Pharma has 18 total employees.

  • What industry is J-Pharma in?

    J-Pharma’s primary industry is Drug Discovery.

  • Is J-Pharma a private or public company?

    J-Pharma is a Public company.

  • What is J-Pharma’s stock symbol?

    The ticker symbol for J-Pharma is 520A.

  • What is the current stock price of J-Pharma?

    As of 20-Nov-2026 the stock price of J-Pharma is $1.98.

  • What is the current market cap of J-Pharma?

    The current market capitalization of J-Pharma is $35.9M.

  • Who are J-Pharma’s competitors?

    Arcturus Therapeutics Holdings, Transgene, Alaunos Therapeutics, TME Pharma, and iBio are some of the 75 competitors of J-Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process